Tag: life sciences
-
Drug Added to Covid-19 Lung Disease Trial
A clinical trial evaluating numerous therapies for a serious lung complication of Covid-19 infections is adding a drug to treat glaucoma to the study.
-
Drug Maker Licenses Low-Dose Vaccine Patch
The pharmaceutical company Merck is licensing a microneedle patch device that delivers vaccines with a small fraction of the dose normally needed by syringes.
-
Health Research Commercialization Company Launched
University of Michigan and health care investor Deerfield Management are creating a new enterprise to bring promising academic life science research to market.
-
Antibody Drug Biotech Raises $105M in Venture Funds
A company that says it has a faster process for discovering therapeutic antibodies is raising $105 million in its second venture finance round.
-
Labs Creating Mask Electronic Sterilization Process
Researchers from academic engineering and biology labs designed an electronic process for sterilizing N95 respirator face masks enabling their safe reuse.
-
Merck Inks Three Covid-19 Vaccine, Therapy Deals
Drug maker Merck today gained a new acquisition, along with collaboration and licensing deals, for vaccines and a therapy for Covid-19 infections.
-
Covid-19 Therapies Designed with Virtual Reality, A.I.
Two companies are using deep learning and virtual reality to design treatments for Covid-19 infections, attacking a different target than most drugs being developed.
-
GSK, Biotech Partner on Crispr Covid-19 Test
A biotechnology company using gene editing for diagnostics is developing a fast, point-of-care Covid-19 test with drug maker GlaxoSmithKline.
-
Covid-19 Vaccine Produces Antibodies in Preclinical Test
Tests with lab animals show a Covid-19 vaccine now in clinical trials produces neutralizing antibodies to prevent coronavirus infections.
-
Venture Producing Covid-19 Antibody Test Kits
A new company formed from a medical research lab is producing test kits for detecting and measuring a person’s Covid-19 antibodies.